point-counterpoint: active surveillance for intermediate-risk prostate cancer - pro
Published 8 months ago • 1.7K plays • Length 9:15Download video MP4
Download video MP3
Similar videos
-
9:59
point-counterpoint: active surveillance for intermediate-risk prostate cancer - con
-
11:13
active surveillance in favorable intermediate-risk prostate cancer
-
17:45
point-counterpoint: oncotype dx genomic prostate score in active surveillance – canary pass study
-
16:11
point-counterpoint q&a w/ dr. lin: oncotype dx genomic prostate score in active surveillance
-
20:50
active surveillance 2021 - from bench to bedside
-
20:23
active surveillance criteria and follow-up protocol
-
50:02
active surveillance for favourable risk prostate cancer
-
28:33
active surveillance results and implications of prospective studies
-
25:24
active surveillance in 2021 part 2: imaging and biomarkers
-
40:52
global grand rounds: active surveillance for prostate cancer with matthew e. nielsen, md, ms, facs
-
7:22
active surveillance in intermediate-risk prostate cancer
-
11:36
point-counterpoint: will conventional imaging become obsolete? – con
-
14:29
active surveillance at johns hopkins: update 2015
-
9:14
prostate cancer active surveillance in 2019
-
18:53
focal therapy for men with intermediate risk prostate cancer
-
23:37
active surveillance who is the right patient and what is the right protocol
-
29:23
how should we monitor patients during surveillance?
-
1:42
active surveillance or intervention in intermediate-risk prostate cancer
-
15:10
prostate cancer focal therapy is it the right time for your practice